Consensus Purple Innovation, Inc.

Equities

PRPL

US74640Y1064

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
1.25 ^USD	+0.81%		-2.34%	+21.36%

May. 07	Earnings Flash (PRPL) PURPLE INNOVATION Reports Q1 Revenue $120M, vs. Street Est of $122.1M	MT
May. 07	Transcript : Purple Innovation, Inc., Q1 2024 Earnings Call, May 07, 2024

Evolution of the average Target Price on Purple Innovation, Inc.

Price target over the last 5 years

History of analyst recommendation changes

37a670df20188d.DZMF4DTqUoVRbwmjz5S3RDvS68K7t3KLlkgZYz2M5rY.S-A81Bm5a-cJK2HEocL2aW3jhPvk_QbE3jtSNV7Uh9VDvlSPRoQBxyAHXA~1d661dac31230bfafd9fb2923b2f7847

Analyst Recommendations on Purple Innovation, Inc.

Purple Innovation Files Registration Statement for Secondary Offering	Mar. 21	MT
Roth MKM Upgrades Purple Innovation to Buy From Neutral, Raises Price Target to $2.50 From $2	Mar. 13	MT
Craig-Hallum Adjusts Price Target on Purple Innovation to $2 From $1, Maintains Hold Rating	Mar. 13	MT
UBS Adjusts Purple Innovation Price Target to $2 From $1, Maintains Neutral Rating	Mar. 13	MT
Wedbush Adjusts Purple Innovation's Price Target to $2.25 From $1.25, Maintains Outperform Rating	Mar. 13	MT
KeyBanc Adjusts Price Target on Purple Innovation to $5 From $6, Maintains Overweight Rating	Jan. 24	MT
Oppenheimer Downgrades Purple Innovation to Perform From Outperform	Nov. 13	MT
Craig-Hallum Downgrades Purple Innovation to Hold From Buy, Cuts Price Target to $1 From $4	Nov. 10	MT
UBS Adjusts Purple Innovation Price Target to $0.80 From $2.75, Maintains Neutral Rating	Nov. 10	MT
KeyBanc Adjusts Price Target on Purple Innovation to $6 From $8, Maintains Overweight Rating	Nov. 10	MT
KeyBanc Adjusts Purple Innovation Price Target to $6 From $8, Maintains Overweight Rating	Nov. 10	MT
Wedbush Lowers Purple Innovation's PT to $1 From $3 After Q3 Revenue, EBITDA Miss Expectations; Keeps Outperform Rating	Nov. 10	MT
UBS Adjusts Purple Innovation Price Target to $2.75 From $3, Maintains Neutral Rating	23-08-10	MT
Wedbush Purple Innovation's PT to $3 From $3.50 After Q2 Miss, Notes Execution Risk, Lower Industry Demand Outlook; Keeps Outperform Rating	23-08-10	MT
UBS Adjusts Purple Innovation Price Target to $3 From $2.75, Maintains Neutral Rating	23-05-11	MT
Wedbush Trims Purple Innovation's Price Target to $3.50 From $5, Notes Execution Risk; Keeps Outperform Rating	23-05-11	MT
UBS Adjusts Purple Innovation Price Target to $2.75 From $6, Maintains Neutral Rating	23-03-21	MT
Wedbush Trims Purple Innovation's Price Target $5 From $6.75, Notes 'Tough' Q4, Start to 2023; Keeps Outperform Rating	23-03-17	MT
KeyBanc Capital Markets Adjusts Price Target on Purple Innovation to $8 From $7, Maintains Overweight Rating	23-02-01	MT
Wedbush Adjusts Purple Innovation's Price Target to $6.75 From $5, Maintains Outperform Rating	23-01-31	MT
UBS Adjusts Purple Innovation Price Target to $6 From $4.75, Maintains Neutral Rating	23-01-30	MT
Keybanc Adjusts Price Target on Purple Innovation to $7.50 From $5, Maintains Overweight Rating	23-01-12	MT
Craig-Hallum Upgrades Purple Innovation to Buy From Hold, Adjusts Price Target to $6 From $4	22-11-10	MT
UBS Adjusts Purple Innovation Price Target to $4.35 From $4, Maintains Neutral Rating	22-09-20	MT
Wedbush Lifts Price Target on Purple Innovation to $5 From $3.30 After Coliseum Offer, Keeps Outperform Rating	22-09-20	MT